AML, Amrad has only 1m cash, 30m FUM and 20m property assets.
They also have over $10m liabilities.
Burning cash at a rate of about 11.2m p.a. and clinical trials still very early stage this stock could go to the 20-30c mark as well.
Any other opinions?
Add to My Watchlist
What is My Watchlist?